Soluble T cell receptor

Details for Australian Patent Application No. 2002321581 (hide)

Owner Medigene Limited

Inventors Jakobsen, Bent Karsten; Glick, Meir

Agent FB Rice

Pub. Number AU-B-2002321581

PCT Number PCT/GB02/03986

PCT Pub. Number WO2003/020763

Priority 60/404,182 16.08.02 US; 0121187.9 31.08.01 GB; 0219146.8 16.08.02 GB

Filing date 30 August 2002

Wipo publication date 18 March 2003

Acceptance publication date 21 February 2008

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07K 14/725 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/404,182 16.08.02 US; 0121187.9 31.08.01 GB; 0219146.8 16.08.02 GB

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002321581

31 January 2008 Alteration of Name

  The name of the applicant has been altered to Medigene Limited 2003

21 February 2008 Application Accepted

  Published as AU-B-2002321581

8 May 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 16 Apr 2008. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street Melbourne VIC 3000

19 June 2008 Standard Patent Sealed

18 September 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 16 Apr 2008

26 February 2009 Assignment Registered

  Medigene Limited The patent has been assigned to Immunocore Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002321582-DISTRIBUTED TRANSACTION PROCESSING SYSTEM

2002321580-A SENSOR UNIT